Gilead Sciences EBITDA 2010-2025 | GILD

Gilead Sciences EBITDA for the quarter ending March 31, 2025 was $3.145B, a 36.68% increase year-over-year.

  • Gilead Sciences 2024 EBITDA was 4.429B, a 56.99% decline from 2023.
  • Gilead Sciences 2023 EBITDA was 10.298B, a 9.17% increase from 2022.
  • Gilead Sciences 2022 EBITDA was 9.433B, a 21.18% decline from 2021.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.

Gilead Sciences EBITDA 2010-2025 | GILD

  • Gilead Sciences 2024 EBITDA was 4.429B, a 56.99% decline from 2023.
  • Gilead Sciences 2023 EBITDA was 10.298B, a 9.17% increase from 2022.
  • Gilead Sciences 2022 EBITDA was 9.433B, a 21.18% decline from 2021.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.